SAN DIEGO, CA and Albuquerque, NM–New evidence supports the role of Exagen’s proprietary blood test in monitoring patients with Systemic Lupus Erythematosus (SLE). Three world-renown lupus centers collaborated to reveal significant association between clinical disease activity and levels of the patented biomarker Erythrocyte-bound C4d (EC4d). SLE is known as the great masquerader and, as this name implies, it is not …
Exagen Points the Way for Patients with Difficult-to-Diagnose Disease
Contact: Brian McEvilly at: [email protected] SAN DIEGO, CA – Exagen Diagnostics, a rheumatology specialty laboratory with offices in Vista, CA, and Albuquerque, NM, is focused on helping patients and their doctors get speedier and more accurate diagnoses. Today, they produce the only validated lupus test on the market incorporating scientifically proven CB-CAPS technology, and it is having a big impact …
Exagen announces collaboration with GSK to drive greater awareness about challenges facing lupus diagnostics and management
Current average time for lupus diagnosis of nearly six years must be improved upon Issued ALBUQUERQUE, NM and SAN DIEGO, CA – Exagen Diagnostics, Inc.today announced a first-of-its kind collaboration with GSK to raise awareness of its laboratory tests, which facilitate early diagnosis and management of systemic lupus erythematosus (SLE), the most common form of lupus, a complex, incurable autoimmune …
Exagen Featured in Five Scientific Posters at 2017 ACR/ARHP Annual Meeting in San Diego
AVISE family of tests including AVISE CTD used to aid in the diagnosis of lupus and other connective tissue diseases, prominent among scientific presentations this year. ALBUQUERQUE, NM and SAN DIEGO, CA, Oct 31, 2017 (GLOBE NEWSWIRE) – Exagen Diagnostics will feature 5 presentations highlighting the usefulness of AVISE® testing at the American College of Rheumatology’s (ACR/ARHP) annual meeting being …
Exagen Inc Closes Series F Equity and Debt Raise Totaling $48 Million
ALBUQUERQUE, NM and SAN DIEGO, CA, Sep 11, 2017 (GLOBE NEWSWIRE) – Exagen Diagnostics Inc.- (“Exagen”}, a commercial stage specialty diagnostic company and exclusive home of AVISE testing, announced today that it has completed two significant capitalization events. The company has entered into a debt financing agreement with an affiliate of lnnovatus Capital Partners, LLC (“lnnovatus”), to provide Exagen Diagnostics …